Pathology Laboratories, INC.

Pathology Laboratories, INC. was paid $25.02M by Medicaid between Jan 2018 and Sep 2024, across 283 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 6.8% of everything it billed.

33Billing provider infoPATHOLOGY LABORATORIES, INC.
TOLEDO, OH 43604

33aNPI1346285988assigned 06/18/2006

33bProvider typeClinical Medical Laboratory

28Total paid$25.02M

24GClaims2,416,463

24DCodes billed283

24AFirst – last monthJan 2018 – Sep 2024

Compared with peers

Next to other Clinical Medical Laboratory providers in Ohio

Rank by total paid#11 of 116

Median peer was paid$313K

This provider vs. median80×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	461,202	$5.65M
2019	391,998	$4.02M
2020	304,055	$3.60M
2021	324,121	$3.73M
2022	337,146	$3.05M
2023	376,724	$3.03M
2024incomplete	221,217	$1.94M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	6.8%	64,133	59,346	$1.70M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	6.4%	63,960	59,210	$1.61M
84443	Thyroid stimulating hormone (TSH)	5.7%	136,131	124,181	$1.43M
80053	Comprehensive metabolic panel	5.1%	181,341	164,810	$1.27M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	5.0%	71,813	65,978	$1.24M
80061	Lipid panel	4.4%	130,944	120,821	$1.11M
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	4.0%	43,190	39,728	$1.01M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	3.9%	188,398	167,983	$971K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	3.1%	48,669	44,112	$767K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	2.8%	37,715	35,916	$695K
83036	Hemoglobin; glycosylated (A1C)	2.2%	93,982	86,976	$556K
36415	Collection of venous blood by venipuncture	2.1%	263,127	232,201	$530K

271 more codes

80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.0%	14,033	$511K
87902		1.9%	2,986	$472K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.7%	5,465	$437K
80050	General health panel	1.7%	18,073	$431K
80074		1.7%	18,924	$431K
86480		1.4%	9,539	$358K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.4%	14,473	$349K
82607		1.3%	35,068	$330K
87522	Neg quan hep c or qual rna	1.2%	12,041	$305K
86803		1.1%	28,078	$272K
84439		1.0%	44,234	$260K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.0%	5,289	$256K
81514		1.0%	2,781	$253K
87086	Culture, bacterial; quantitative colony count, urine	<1%	41,199	$242K
87799		<1%	2,112	$182K
84153		<1%	15,390	$182K
82746		<1%	20,562	$180K
84403		<1%	9,984	$171K
83013		<1%	3,627	$165K
87340		<1%	23,142	$162K
84481		<1%	14,246	$157K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,162	$154K
86003		<1%	2,430	$150K
84702		<1%	13,472	$141K
87480		<1%	8,937	$130K
86696		<1%	9,799	$129K
82728		<1%	14,135	$125K
86592		<1%	41,375	$125K
87510		<1%	8,949	$123K
83001		<1%	8,134	$114K
82670		<1%	5,179	$106K
80081		<1%	2,045	$99K
83540		<1%	22,275	$97K
86762		<1%	9,372	$89K
87660		<1%	6,910	$87K
83880		<1%	3,815	$87K
87481		<1%	4,706	$87K
85027		<1%	18,951	$84K
84146		<1%	5,520	$81K
83002		<1%	5,431	$80K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	296	$80K
86235		<1%	1,456	$79K
80055		<1%	1,378	$79K
87512		<1%	2,398	$78K
86695		<1%	9,440	$77K
86038		<1%	8,789	$77K
83550		<1%	13,701	$76K
82043		<1%	18,528	$74K
87529		<1%	1,704	$74K
80048	Basic metabolic panel (calcium, ionized)	<1%	15,118	$72K
87070		<1%	11,736	$70K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	2,668	$70K
82570		<1%	19,011	$66K
84144		<1%	4,333	$64K
86706		<1%	8,123	$64K
82105		<1%	5,054	$62K
86787		<1%	5,224	$58K
83735		<1%	14,496	$58K
83970		<1%	2,341	$54K
82248		<1%	16,714	$54K
87186		<1%	8,240	$50K
82627		<1%	2,892	$48K
84270		<1%	3,083	$46K
88141		<1%	2,539	$45K
87081		<1%	8,103	$44K
81001		<1%	20,051	$44K
84402		<1%	2,457	$44K
86769		<1%	1,220	$43K
84550		<1%	13,776	$42K
83516		<1%	1,641	$42K
84480		<1%	4,359	$42K
87077		<1%	6,775	$41K
86705		<1%	4,779	$40K
83525		<1%	5,261	$40K
84436		<1%	10,138	$40K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	2,024	$40K
86376		<1%	3,748	$39K
82677		<1%	1,835	$39K
80076		<1%	6,854	$39K
81513		<1%	564	$39K
83655		<1%	3,544	$37K
86850		<1%	7,903	$36K
88142		<1%	2,286	$35K
82140		<1%	3,436	$35K
86708		<1%	3,790	$32K
86694		<1%	3,333	$31K
86704		<1%	3,343	$31K
82950		<1%	8,025	$30K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	536	$30K
86800		<1%	2,503	$29K
82977		<1%	5,608	$28K
82652		<1%	1,412	$28K
86141		<1%	3,067	$27K
86431		<1%	6,619	$27K
84207		<1%	984	$26K
87625		<1%	2,190	$26K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	233	$26K
86140		<1%	7,982	$25K
83020		<1%	2,225	$24K
84703		<1%	4,178	$24K
83690		<1%	5,077	$24K
86336		<1%	1,849	$23K
82784		<1%	1,377	$23K
85379		<1%	3,172	$22K
85652		<1%	12,554	$22K
84460		<1%	6,978	$22K
84425		<1%	1,102	$22K
84450		<1%	6,638	$21K
86665		<1%	781	$20K
83721		<1%	4,239	$19K
87520		<1%	1,239	$19K
86160		<1%	1,252	$19K
82378		<1%	1,607	$19K
82785		<1%	1,450	$19K
82150		<1%	4,337	$18K
87109		<1%	1,335	$18K
83090		<1%	1,831	$18K
85610		<1%	6,839	$17K
82565		<1%	4,956	$17K
86901		<1%	7,750	$16K
87088		<1%	2,653	$16K
86780		<1%	1,642	$16K
86900		<1%	7,800	$15K
80164		<1%	2,002	$15K
83014		<1%	2,430	$15K
86225		<1%	1,591	$15K
85651		<1%	4,746	$14K
81003		<1%	9,248	$14K
87800		<1%	548	$14K
87631		<1%	129	$14K
86765		<1%	1,284	$14K
86735		<1%	1,260	$14K
87563		<1%	666	$14K
82672		<1%	838	$13K
82951		<1%	1,467	$12K
82040		<1%	4,547	$12K
87255		<1%	394	$12K
84520		<1%	4,186	$12K
86709		<1%	1,495	$12K
84479		<1%	3,275	$11K
87147		<1%	2,845	$11K
82550		<1%	2,178	$10K
84075		<1%	3,469	$10K
84100		<1%	3,774	$10K
86334		<1%	575	$10K
86147		<1%	193	$10K
82310		<1%	2,832	$10K
82247		<1%	3,418	$10K
82947		<1%	3,231	$9K
86304		<1%	740	$9K
86812		<1%	564	$9K
84155		<1%	4,056	$9K
86381		<1%	593	$9K
85018		<1%	4,528	$9K
84134		<1%	1,111	$8K
87486		<1%	302	$8K
87581		<1%	304	$8K
86664		<1%	648	$8K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	220	$8K
86663		<1%	692	$8K
82330		<1%	1,011	$8K
85730		<1%	2,243	$7K
86200		<1%	827	$7K
85060		<1%	1,079	$7K
85014		<1%	3,725	$7K
83615		<1%	1,488	$7K
81241		<1%	133	$7K
80348		<1%	1,064	$7K
80349		<1%	1,074	$7K
86677		<1%	221	$6K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	266	$6K
80051		<1%	1,410	$6K
80178		<1%	1,315	$6K
82533		<1%	569	$6K
84156		<1%	2,404	$6K
84132		<1%	1,769	$5K
87449		<1%	443	$5K
83718		<1%	1,002	$5K
88185		<1%	14	$5K
86146		<1%	176	$5K
82374		<1%	1,536	$5K
84295		<1%	1,484	$5K
82435		<1%	1,479	$5K
82274		<1%	407	$4K
86060		<1%	830	$4K
87205		<1%	1,244	$4K
87536		<1%	89	$4K
80069		<1%	780	$4K
86015		<1%	589	$4K
87252		<1%	191	$4K
82465		<1%	1,193	$4K
87350		<1%	540	$4K
86707		<1%	522	$4K
87498		<1%	130	$3K
84478		<1%	807	$3K
82952		<1%	815	$3K
86039		<1%	375	$3K
87634		<1%	137	$3K
86364		<1%	295	$3K
87427		<1%	401	$3K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	770	$3K
87517		<1%	93	$3K
87045		<1%	347	$3K
87071		<1%	350	$3K
83883		<1%	227	$3K
80358		<1%	255	$2K
87046		<1%	300	$2K
86593		<1%	704	$2K
84140		<1%	186	$2K
87209		<1%	132	$2K
80354		<1%	238	$2K
85045		<1%	607	$2K
83921		<1%	120	$2K
80324		<1%	219	$2K
84466		<1%	168	$2K
80353		<1%	211	$2K
83704		<1%	69	$2K
80346		<1%	170	$2K
85613		<1%	208	$2K
84154		<1%	142	$2K
87400		<1%	81	$2K
84165		<1%	232	$1K
83520		<1%	20	$1K
87177		<1%	166	$1K
86258		<1%	115	$1K
83930		<1%	331	$1K
80361		<1%	66	$1K
84482		<1%	131	$1K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	105	$983.48
84681		<1%	54	$953.23
87075		<1%	117	$939.71
87110		<1%	67	$885.46
86870		<1%	41	$802.17
88189		<1%	13	$733.84
86308		<1%	151	$709.06
86356		<1%	17	$700.26
88184		<1%	14	$546.20
87102		<1%	76	$537.85
80175		<1%	49	$500.76
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	828	$487.63
84445		<1%	13	$451.70
80373		<1%	47	$449.87
85049		<1%	169	$442.98
80183		<1%	44	$439.14
88342		<1%	20	$410.48
80177		<1%	49	$408.96
86618		<1%	25	$408.02
83498		<1%	14	$336.35
86359		<1%	17	$328.84
86357		<1%	17	$328.84
80185		<1%	28	$327.91
81596		<1%	18	$324.84
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	35	$263.18
87324		<1%	27	$256.49
85048		<1%	274	$248.49
84305		<1%	13	$228.29
84630		<1%	26	$226.34
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	15	$225.42
83695		<1%	16	$182.82
80356		<1%	25	$159.15
82595		<1%	30	$132.12
82103		<1%	21	$102.40
84484		<1%	13	$98.57
85384		<1%	15	$89.09
84590		<1%	13	$75.07
80159		<1%	15	$68.60
85670		<1%	14	$54.65
85732		<1%	15	$36.57
86701		<1%	14	$8.78
85041		<1%	12	$4.83
P3001	Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHUSSONG, JERRY (PRESIDENT)